Semiquantitative Assessment of Hirsutism in 850 Patients with Polycystic Ovary Syndrome and 2,988 Control Women in China

    October 2014 in “ Endokrynologia Polska
    Meifong Wong, Xiaomiao Zhao, Hong Yu, Dongzi Yang
    Image of study
    TLDR Excessive hair growth is much more common in Chinese women with PCOS than in the general population.
    The study conducted a semiquantitative assessment of hirsutism in 850 Chinese women with Polycystic Ovary Syndrome (PCOS) and 2,988 women from the general population. The study found that hirsutism, or excessive hair growth, was significantly higher in PCOS patients (43.2% with a Ferriman-Gallwey (FG) score of 5 or above) compared to the general population (10% with a FG score of 5 or above). The most common areas for terminal hair growth in both groups were the lips and upper back. However, in severe cases (score 3-4), the lips and thighs were the most common areas. The study concluded that an mFG score of 5 or above is abnormal for the general population and forms almost half of the possibility of diagnosing PCOS in Chinese women. The FG score was found to have good predictive value for diagnosing PCOS in Chinese women.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 24 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    5 / 5 results